Day One Biopharmaceuticals
DAWN
DAWN
156 hedge funds and large institutions have $1.03B invested in Day One Biopharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 48 increasing their positions, 48 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
14% less capital invested
Capital invested by funds: $1.2B → $1.03B (-$173M)
31% less call options, than puts
Call options by funds: $3.07M | Put options by funds: $4.45M
50% less funds holding in top 10
Funds holding in top 10: 6 → 3 (-3)
Holders
156
Holding in Top 10
3
Calls
$3.07M
Puts
$4.45M
Top Buyers
| 1 | +$17.2M | |
| 2 | +$16M | |
| 3 | +$14.1M | |
| 4 |
B
Braidwell
Stamford,
Connecticut
|
+$11.9M |
| 5 |
ABG
Ally Bridge Group
New York
|
+$7.39M |
Top Sellers
| 1 | -$24M | |
| 2 | -$21.8M | |
| 3 | -$6.86M | |
| 4 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
-$5.98M |
| 5 |
SCM
Superstring Capital Management
New York
|
-$5.78M |